Article
Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients.
Oncology research - 7 May 2019
Zhang Kai, Chen Huajun, Wang Ye, Yang Lin, Zhou Chengzhi, Yin Weiqiang, Wang Guangsuo, Mao Xinru, Xiang Jianxing, Li Bing, Zhang Tengfei, Fei Shihong
Abstract excerpt
RET rearrangement has been proven as an oncogenic driver in patients with lung cancer. However, the prevalence, clinical characteristics, molecular features, and therapeutic options in RET-rearranged patients remain unclear, especially in Chinese lung cancer patients. We retrospectively collected 6,125 Chinese lung cancer patients who have been profiled using next-generation sequencing (NGS). The clinical...
Topics
Join the communities discussing this publication.